Golden
Mediphase Venture Partners

Mediphase Venture Partners

A Newton-based venture capital firm that invests in health care and life sciences companies

Mediphase Venture Partners is a venture capital firm in Newton that prefers to invest in life sciences and healthcare companies with a focus on biopharmaceutical technology and life sciences information. Founded in 1999 by Lawrence Miller and Paul Howard in Newton, Massachusetts, the firm invests in early stage ventures, late stage ventures, and private equity rounds. The notable investment portfolio of Mediphase Venture Partners includes Relypsa,Tetraphase Pharmaceuticals, Wellpartner, and Concert Pharmaceuticals. As of February 2020, Mediphase Venture Partners has made 21 investments. Their most recent investment was on Aug 14, 2012, when Relypsa raised $80M. Mediphase Venture Partners has had seven exits, the most notable of which include Relypsa, Concert Pharmaceuticals, and PatientKeeper.

Timeline

1999

Founded

Funded Companies

Company
Description
Website
Industry
Location

A biopharmaceutical company developing drugs to treat cardiovascular and renal diseases

1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Amanda Cobb

Operations Manager

David C. Lubner

Financial Consultant

Lawrence G. Miller

Founding Partner

Paul A. Howard

Founding Partner

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services

Tetraphase Pharmaceuticals

Concert Pharmaceuticals

Relypsa

Wellpartner

References